ZTS

Q: What is the price of Zoetis (ZTS) today?

The price of Zoetis (ZTS) today is US$ 141,11, with a variation of -24.96% compared to the last year. The price of Zoetis (ZTS) started the year trading around US$ 162,93 and today it is at US$ 141,11. Follow the real-time price chart, the historical price of Zoetis (ZTS), and stock data from Ibovespa and international markets.

Q: When does Zoetis (ZTS) pay dividends?

Zoetis (ZTS) distributed dividends in the last year,in the months of March, June and September totaling US$ 1,50. The Dividend Yield for the last 12 months is 1,32%.

Q: Zoetis (ZTS) is it worth it?

Currently, Zoetis (ZTS) is priced at US$ 141,11, with a P/E of 24,61%, representing a deviation of 34,32% from its historical average P/E. In the last year, the stock showed a variation of -24.96% in its price and distributed US$ 1,50 in dividends, resulting in a Dividend Yield of 1,32%. The total shareholder return was -24,96%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Zoetis (ZTS)?

Investing in stocks of Zoetis (ZTS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Zoetis (ZTS) yield today?

The yield of Zoetis (ZTS) was -5,56% in the last month, -24,96% in the last year and -12,67% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 1,93 in dividends, um Dividend Yield de 1,32%.If you wanted to buy 100 stocks of Zoetis (ZTS) today, the total investment would be US$ 14.111,00, based on the current price of US$ 141,11.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 10.588,89In 5 years: US$ 12.323,14In 10 years: 50.699,41It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Zoetis Inc.

Price

US$ 141,11

variation (12m)

-24,96%

p/l

24,61

p/vp

13,09

DIVIDEND YIELD

1,32%

price ZTS

BVMF

ZTS

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of ZTS

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

-5,56%

3 months

-8,94%

1 year

-24,96%

2 years

-17,26%

5 years

-12,67%

10 years

259,29%

real profitability

profitability minus inflation.

1 month

-5,56%

3 months

-9,28%

1 year

-28,25%

2 years

-24,48%

5 years

-35,47%

10 years

115,11%

Indicators ZTS

check out the fundamentals of Zoetis shares

P/E

24,61

Sector: -3,47 Industry: -3,47

P/SALES RATIO (PSR)

6,89

Sector: -4,23 Industry: -4,23

P/BV

13,09

Sector: 1,89 Industry: 1,89

DIVIDEND YIELD (DY)

1,32%

Sector: - Industry: -

ROA

18,29%

Sector: -63,87% Industry: -63,87%

ROE

53,20%

Sector: -70,87% Industry: -70,87%

ROIC

28,37%

Sector: -2.084,36% Industry: -2.084,36%

NET MARGIN

28,00%

Sector: -41,75% Industry: -41,75%

GROSS MARGIN

72,22%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

37,95%

Sector: -41,04% Industry: -41,04%

P/EBITDA

16,11

Sector: -3,65 Industry: -3,65

P/EBIT

18,32

Sector: -3,64 Industry: -3,64

P/ASSET

4,50

Sector: 1,41 Industry: 1,41

BVPS

11,18

Sector: 1,84 Industry: 1,84

EPS

5,95

Sector: -2,20 Industry: -2,20

EQUITY / ASSETS

0,34

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

6,42%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

9,35%

Sector: - Industry: -

FAIR PRICE OF Zoetis ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 141,11

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-72,58%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

ZTS indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,80	5,78	32,50%	2,69%	US$ 453,87 B	27,75%
PFE	16,92	1,75	10,33%	6,25%	US$ 155,60 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	16,20	10,21	62,99%	2,83%	US$ 265,17 B	34,74%
MRK	12,67	4,56	36,03%	3,59%	US$ 223,87 B	28,16%
AZN	28,39	5,90	20,79%	1,83%	US$ 264,46 B	16,23%
BMY	17,97	5,29	29,44%	5,41%	US$ 92,49 B	10,71%
GILD	19,99	7,16	35,82%	2,79%	US$ 140,30 B	24,71%
HALO	14,26	25,08	175,93%	0,00%	US$ 8,35 B	48,21%
REGN	13,97	2,10	15,06%	0,44%	US$ 63,00 B	31,83%
AMGN	30,70	21,58	70,29%	3,15%	US$ 160,26 B	14,67%
VRTX	28,59	6,03	21,11%	0,00%	US$ 103,65 B	31,22%
MCK	24,89	-106,90	-429,55%	0,40%	US$ 92,26 B	0,97%
CAH	26,56	-13,96	-52,54%	1,31%	US$ 36,76 B	0,60%
ADMA	17,05	8,87	52,03%	0,00%	US$ 3,53 B	43,51%
BIIB	13,23	1,33	10,08%	0,00%	US$ 23,50 B	17,46%
HRMY	8,91	2,01	22,58%	0,00%	US$ 1,55 B	22,19%

comparison of ZTS with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History ZTS

current DY: 1,32%

5-year average DY: 0,74%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	18/07/2025	03/09/2025	0,50000000
Dividends	21/04/2025	03/06/2025	0,50000000
Dividends	21/01/2025	04/03/2025	0,50000000
Dividends	31/10/2024	03/12/2024	0,43200000
Dividends	18/07/2024	04/09/2024	0,43200000
Dividends	19/04/2024	04/06/2024	0,43200000
Dividends	19/01/2024	01/03/2024	0,43200000
Dividends	01/11/2023	01/12/2023	0,37500000
Dividends	21/07/2023	01/09/2023	0,37500000
Dividends	21/04/2023	01/06/2023	0,37500000
Dividends	20/01/2023	01/03/2023	0,37500000
Dividends	01/11/2022	01/12/2022	0,32500000
Dividends	21/07/2022	01/09/2022	0,32500000
Dividends	21/04/2022	01/06/2022	0,32500000
Dividends	20/01/2022	01/03/2022	0,32500000
Dividends	29/10/2021	01/12/2021	0,25000000
Dividends	21/07/2021	01/09/2021	0,25000000
Dividends	21/04/2021	01/06/2021	0,25000000
Dividends	20/01/2021	01/03/2021	0,25000000
Dividends	21/10/2020	01/12/2020	0,20000000
Dividends	17/07/2020	01/09/2020	0,20000000
Dividends	17/04/2020	01/06/2020	0,20000000
Dividends	17/01/2020	03/03/2020	0,20000000
Dividends	22/10/2019	02/12/2019	0,16400000
Dividends	19/07/2019	03/09/2019	0,16400000
Dividends	18/04/2019	03/06/2019	0,16400000
Dividends	18/01/2019	01/03/2019	0,16400000
Dividends	20/11/2018	03/12/2018	0,12600000
Dividends	20/07/2018	04/09/2018	0,12600000
Dividends	20/04/2018	01/06/2018	0,12600000
Dividends	19/01/2018	01/03/2018	0,12600000
Dividends	09/11/2017	01/12/2017	0,10500000
Dividends	15/06/2017	01/09/2017	0,10500000
Dividends	06/04/2017	01/06/2017	0,10500000
Dividends	20/01/2017	01/03/2017	0,10500000
Dividends	03/11/2016	01/12/2016	0,09500000
Dividends	30/06/2016	30/08/2016	0,09500000
Dividends	07/04/2016	01/06/2016	0,09500000
Dividends	21/01/2016	01/03/2016	0,09500000
Dividends	05/11/2015	01/12/2015	0,08300000
Dividends	13/08/2015	01/09/2015	0,08300000
Dividends	09/04/2015	02/06/2015	0,08300000
Dividends	22/01/2015	03/03/2015	0,08300000
Dividends	05/11/2014	02/12/2014	0,07200000
Dividends	20/08/2014	02/09/2014	0,07200000
Dividends	28/04/2014	02/06/2014	0,07200000
Dividends	30/01/2014	04/03/2014	0,07200000
Dividends	01/11/2013	02/12/2013	0,06500000
Dividends	01/08/2013	02/09/2013	0,06500000
Dividends	01/05/2013	06/06/2013	0,06500000

ABOUT THE COMPANY Zoetis

Zoetis Inc.

Average user rating I10

5.0 (55 people)

Estados Unidos

13 years

Foundation: 2012

2013

Year of debut on the stock exchange - 12 years

11.300

Employees

The Company Zoetis Inc. (Estados Unidos), is listed on NYSE with a market value of $ 65,16 Billions, having a net worth of $ 4,98 Billions.

With a total of 11.300 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 9,46 Billions, which generated a profit in the amount of $ 2,65 Billions.

As for its main indicators, the Company has a P/E ratio of 24,61, a P/BV ratio of 13,09 and in the last 12 months the dividend yield of ZTS was at 1,32%.

The Company is traded internationally through the ticker ZTS.

Market value

US$ 65,16 Billions

Net worth

US$ 4,98 Billions

US$ 4.977.000.000,00

Assets

US$ 14,48 Billions

US$ 14.479.000.000,00

Total Number of Shares

445,00 Milhões

445.000.000

Average Daily Trading Volume

US$ 3,03 Milhões

US$ 3.030.562,00

Sector

Health Care

Industry

Biotechnology

ZTS

ZTS revenue and profits

ZTS results

DRAG THE FRAME TO SEE MORE DATA

ZTS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 763,55 51,69% (12 M)

P/L

24,89

0,40%

ROE

-429,55%

P/VP

-106,90

CAH - Cardinal Health

US$ 156,88 42,09% (12 M)

P/L

26,56

1,31%

ROE

-52,54%

P/VP

-13,96

JNJ - Johnson & Johnson

US$ 190,72 21,94% (12 M)

P/L

17,80

2,69%

ROE

32,50%

P/VP

5,78

MRK - Merck & Co.

US$ 85,99 --18,73% (12 M)

P/L

12,67

3,59%

ROE

36,03%

P/VP

4,56

ABBV - AbbVie

US$ 230,50 23,82% (12 M)

P/L

108,79

2,79%

ROE

-2.726,81%

P/VP

-2.966,40

PFE - Pfizer

US$ 24,78 --8,77% (12 M)

P/L

16,92

6,25%

ROE

10,33%

P/VP

1,75

AZN - AstraZeneca

US$ 84,53 11,61% (12 M)

P/L

28,39

1,83%

ROE

20,79%

P/VP

5,90

Frequently Asked Questions

What is the price of Zoetis (ZTS) today?

The price of Zoetis (ZTS) today is US$ 141,11, with a variation of -24.96% compared to the last year. The price of Zoetis (ZTS) started the year trading around US$ 162,93 and today it is at US$ 141,11. Follow the real-time price chart, the historical price of Zoetis (ZTS), and stock data from Ibovespa and international markets.

When does Zoetis (ZTS) pay dividends?

Zoetis (ZTS) distributed dividends in the last year,in the months of March, June and September totaling US$ 1,50. The Dividend Yield for the last 12 months is 1,32%.

Zoetis (ZTS) is it worth it?

Currently, Zoetis (ZTS) is priced at US$ 141,11, with a P/E of 24,61%, representing a deviation of 34,32% from its historical average P/E. In the last year, the stock showed a variation of -24.96% in its price and distributed US$ 1,50 in dividends, resulting in a Dividend Yield of 1,32%. The total shareholder return was -24,96%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Zoetis (ZTS)?

Investing in stocks of Zoetis (ZTS) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Zoetis (ZTS) yield today?

The yield of Zoetis (ZTS) was -5,56% in the last month, -24,96% in the last year and -12,67% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 1,93 in dividends, um Dividend Yield de 1,32%.

If you wanted to buy 100 stocks of Zoetis (ZTS) today, the total investment would be US$ 14.111,00, based on the current price of US$ 141,11.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 10.588,89
In 5 years: US$ 12.323,14
In 10 years: 50.699,41

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

ZTS

Zoetis Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of ZTS

check out the fundamentals of Zoetis shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 1,32%

5-year average DY: 0,74%

type

date with

payment date

value

ABOUT THE COMPANY Zoetis

Zoetis Inc.

Estados Unidos

13 years

2013

11.300

PROFIT X PRICE ZTS

ZTS results

ZTS cash flow

evolution of assets - ZTS

ZTS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions